Nancy Miller-Rich

Board Member at Intercept Pharma, Aldeyra Therapeutics, Kadmon Holdings, 4DMT, Attralus and TB Alliance. Founder and advisor to Ten63

Role
Board Member at 4D Molecular Therapeutics
Location
Morristown, NJ, US
LinkedIn followers
500 followers
General Business & ManagementView LinkedIn profile

About Nancy Miller-Rich

Global enterprise-wide thinking and business building skills garnered from 35 years of experience in the healthcare industry. Has been a member of the operating committees of Merck Global Human Health division, as well as Schering Plough Consumer Healthcare Products, and has held broad commercial roles. Most recently was Senior Vice-President, Global Business Development & Licensing, Strategy and Commercial Support for Human Health at Merck. Specific responsibilities included global BD, alliance management, strategy, commercial assessment, forecasting, market research, promotion, social media and commercial digital transformation. Currently holds multiple board positions in biotech.

Experience

  1. Board Member

    4D Molecular Therapeutics

    Nov 2020 — Present · CA, US

Skills

  • Product Launch
  • Pharmaceutical Industry
  • Clinical Development
  • Market Access
  • Global Marketing
  • Sales Effectiveness
  • Strategy
  • Pharmaceutical Sales
  • Business Development
  • Cross-Functional Team Leadership

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Nancy Miller-Rich — Board Member at 4D Molecular Therapeutics in Morristown, NJ, US | Unifers